Carnosine Supplementation Mitigates Brain Tissue Markers of Oxidative Stress in a Rat Model of Fulminant Hepatic Failure
Journal Title: Trends in Pharmaceutical Sciences - Year 2017, Vol 3, Issue 3
Abstract
Fulminant hepatic failure is a deleterious clinical complication, which leads to hyperammonemia. Ammonia is a noxious neurotoxic agent, which affects brain tissue through different mechanisms. On the other hand, it is well-known that oxidative stress and its consequences play a major role in the pathogenesis of ammonia-induced brain injury. Carnosine is a dipeptide abundantly found in the human central nervous system (CNS). This peptide is widely investigated for its neuroprotective properties. The current study aimed to evaluate the effect of carnosine supplementation on oxidative stress markers in the brain tissue of a rat model of fulminant hepatic failure and hyperammonemia. Animals received thioacetamide (400 mg/kg, i.p, for three consecutive days at 24-hr intervals) as a model of acute liver failure and hyperammonemia. Several serum biochemical parameters, in addition to plasma and brain ammonia level, were monitored. On the other hand, brain tissue markers of oxidative stress including reactive oxygen species (ROS) formation, lipid peroxidation, tissue glutathione content, and total antioxidant capacity were measured. It was found that plasma and brain ammonia was increased, and serum markers of liver injury were significantly elevated in the thioacetamide-treated group. On the other hand, an increase in markers of oxidative stress, including ROS formation, lipid peroxidation, glutathione depletion, and decreased tissue antioxidant capacity, was evident in the brain of thioacetamide-treated animals. It was found that carnosine supplementation (250, 500, and 1000 mg/kg, i.p) decreased serum markers of liver injury, mitigated brain, and plasma ammonia level, and alleviated brain tissue markers of oxidative stress. These data suggest carnosine as a potential neuroprotective agent with therapeutic capability against ammonia-induced CNS injury during hepatic encephalopathy.
Authors and Affiliations
Akram Jamshidzadeh, Narges Abdoli, Hossein Niknahad, Negar Azarpira, Somayeh Mousavi, Elnaz Mardani, Mojgan Abasvali, Reza Heidari
Keywords
Related Articles
- EP ID EP339333
- DOI -
- Views 130
- Downloads 0
The Hepatoprotective Role of Thiol Reductants against Mitoxantrone-Induced Liver Injury
Mitoxantrone is an anthracycline antibiotic highly effective against various human cancers. Hepatotoxicity is associated with mitoxantrone administration. On the other hand, there is no effective therapeutic option again...
The potential effects of non-renal factors, glucocorticoid treatment and hematological malignancies, on serum cystatin C level
Cystatin C as a novel marker of kidney function may have some drawbacks in clinical practice. The aim of the present study was to assess the impact of glucocorticoid therapy and hematological malignancies on serum cystat...
Analysis of six populations of Commiphora myrrha (Nees) Engl. oleo-gum resin
True myrrh is produced by wounding the plant Commiphora myrrha (Nees) Engl. A number of oleo-gum-resins are produced from various species of Commiphora. Many of these gummy substances resemble myrrh; and sometimes are us...
Effect of Topical Phenytoin in Treatment of Corneal Epithelial Defects in Rabbits
Re-epithelialization of corneal epithelium is a major problem in delayed corneal wound healing. Phenytoin has been used topically for different types of cutaneous wounds and ulcers. The aim of this study was to assess th...
N-Phenyl Ureidobenzenesulfonate derivatives as novel anticancer agents: QSAR and Molecular docking studies
DNA double strand-breaks (DSBs) are the most deleterious lesions that can affect the genome of living beings and are lethal if not quickly and properly repaired. Recently, N-phenyl ureidobenzenesulfonates (PUB-SOs) as tu...